Skip to main content
Premium Trial:

Request an Annual Quote

Illumina CEO Sold $3.3M Worth of Company Stock Since Start of 2006

NEW YORK (GenomeWeb News) - Illumina CEO Jay Flatley sold 2,500 shares of the company's stock at $35.04 apiece for total proceeds of $87,600 on Aug. 10, according to documents filed with the Securities and Exchange Commission on Monday.
He sold 14,000 shares this month before last week's transaction for total proceeds of $515,466. He currently owns 647,998 shares of Ilumina stock.
Shares in Illumina were down 6.8 percent, or $2.34, to $32.09 in mid-afternoon trading today. 
Flatley has sold 119,500 shares since the beginning of the year, pocketing almost $3.3 million in proceeds.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.